5 completed, 1 recruiting, 1 terminated, 1 unknown. 8 Phase 2, 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 5, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 3 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Sorbitol: new trials by email Literature Review of Sorbitol trials Research Report on Sorbitol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain Intravenous oxytocin, Intravenous placebo, Intranasal oxytocin - Pain, Acute | Phase 2 | Completed | Wake Forest University Health Sciences | 24 | 2025-11-05 | 2026-06-30 |
| Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer Sorbitol + PD-1 inhibitor + SOX chemotherapy, PD-1 inhibitor + SOX chemotherapy - Gastric Junction Adenocarcinoma, Gastric Cancer | Phase 2 | Recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 86 | 2024-11-01 | 2026-08-18 |
| Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients Hydroxychloroquine + Metabolic cofactor supplementation, Hydroxychloroquine + Sorbitol - COVID-19 | Phase 2 / Phase 3 | Terminated | ScandiBio Therapeutics AB | 100 | 2020-09-21 | 2025-02-10 |
| Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients Metabolic Cofactor Supplementation, Sorbitol - Alzheimer Disease, Parkinson Disease | Phase 2 | Completed | Istanbul Medipol University Hospital | 120 | 2019-12-02 | 2022-08-08 |
| Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease Metabolic Cofactor Supplementation, Sorbitol - Non-alcoholic Fatty Liver Disease (NAFLD) | Phase 2 | Completed | ScandiBio Therapeutics AB | 32 | 2019-07-20 | 2025-02-10 |
| Gait Analysis Following Knee Viscosupplementation hyaluronic acid with mannitol, hyaluronic acid with sorbitol, Placebos - Gait, Knee Osteoarthritis | Phase 2 / Phase 3 | Completed | Brigitte Jolles, MD | 22 | 2013-05-01 | 2018-08-17 |
| Effect of Xylitol on Oral Microbiota in Children xylitol, sorbitol - Bacterial Infections | Phase 1 / Phase 2 | Completed | Kuwait University | 122 | 2012-03-01 | 2015-08-10 |
| Effect of Erythritol and Xylitol on Dental Caries Prevention in Children A, erythritol, xylitol, C, sorbitol - Dental Caries | Phase 2 / Phase 3 | Unknown | University of Tartu | 450 | 2008-01-01 | 2010-02-04 |
Acute Pain (1) · Agnosia (1) · Alzheimer Disease (1) · Bacterial Infections (1) · COVID-19 (1) · Dental Caries (1) · Non-alcoholic Fatty Liver Disease (1) · Osteoarthritis, Knee (1) · Parkinson Disease (1) · Stomach Neoplasms (1)
ScandiBio Therapeutics AB (2) · Brigitte Jolles, MD (1) · Istanbul Medipol University Hospital (1) · Kuwait University (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · University of Tartu (1) · Wake Forest University Health Sciences (1)
Turkey (Türkiye) (3) · China (1) · Estonia (1) · Kuwait (1) · Switzerland (1) · United States (1)
Eino Honkala, PhD (2) · Brigitte Brigitte (1) · Burak Yulug, MD, PhD (1) · James C Eisenach, MD (1) · Lutfu Hanoglu, MD, PhD (1) · Mare Saag, PhD (1)
PMID 22607272, PMID 24095985, PMID 24852946, PMID 27806364, PMID 30999906, PMID 31024734, PMID 34694070, PMID 36703196, PMID 39816194